Webinar | Women’s Nutrition: Nourishing Womanhood From Pregnancy To Menopause
11 September | 12 PM ET: Register Now

Genomadix

Genomadix develops molecular tests in the areas of infectious disease, precision medicine, and water safety testing.
2021
02-Oct
02-10
Kanata, Ontario, Canada
  • Pathology & Diagnostics
  • Personalized Medicine Technologies
  • Water Purifiers

Innovation

Industry Problem

Genomic and biomarker data are complex and are not consistently converted into clear, patient-specific diagnostic or treatment decisions.

R&D Focus

Genomics and multi-omics for patient stratification and treatment selection

Innovative Solution

Genomadix develops molecular tests in the areas of infectious disease, precision medicine, and water safety testing.

Investment Funding

Last Funding Stage

Corporate Round

Last Funding Date

29-08-2022

Lead Investors

Mayo Clinic

About

Genomadix develops molecular tests in the areas of infectious disease, precision medicine, and water safety testing.

Something missing or incorrect on this page? Help us enrich this information